Leveraging the Treg-intrinsic CTLA4–PKCη signaling pathway for cancer immunotherapy

Guardado en:

Detalles Bibliográficos
Autores principales:	Hsin-Yu Liu, Christophe Pedros, Kok-Fai Kong, Ann J Canonigo-Balancio, Wen Xue, Amnon Altman
Formato:	article
Lenguaje:	EN
Publicado:	BMJ Publishing Group 2021
Materias:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/6b0727518baf4f5588b97fc3c4c8adbd
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:6b0727518baf4f5588b97fc3c4c8adbd
record_format	dspace
spelling	oai:doaj.org-article:6b0727518baf4f5588b97fc3c4c8adbd2021-11-20T11:30:07ZLeveraging the Treg-intrinsic CTLA4–PKCη signaling pathway for cancer immunotherapy10.1136/jitc-2021-0027922051-1426https://doaj.org/article/6b0727518baf4f5588b97fc3c4c8adbd2021-09-01T00:00:00Zhttps://jitc.bmj.com/content/9/9/e002792.fullhttps://doaj.org/toc/2051-1426Hsin-Yu LiuChristophe PedrosKok-Fai KongAnn J Canonigo-BalancioWen XueAmnon AltmanBMJ Publishing GrouparticleNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENJournal for ImmunoTherapy of Cancer, Vol 9, Iss 9 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
spellingShingle	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Hsin-Yu Liu Christophe Pedros Kok-Fai Kong Ann J Canonigo-Balancio Wen Xue Amnon Altman Leveraging the Treg-intrinsic CTLA4–PKCη signaling pathway for cancer immunotherapy
format	article
author	Hsin-Yu Liu Christophe Pedros Kok-Fai Kong Ann J Canonigo-Balancio Wen Xue Amnon Altman
author_facet	Hsin-Yu Liu Christophe Pedros Kok-Fai Kong Ann J Canonigo-Balancio Wen Xue Amnon Altman
author_sort	Hsin-Yu Liu
title	Leveraging the Treg-intrinsic CTLA4–PKCη signaling pathway for cancer immunotherapy
title_short	Leveraging the Treg-intrinsic CTLA4–PKCη signaling pathway for cancer immunotherapy
title_full	Leveraging the Treg-intrinsic CTLA4–PKCη signaling pathway for cancer immunotherapy
title_fullStr	Leveraging the Treg-intrinsic CTLA4–PKCη signaling pathway for cancer immunotherapy
title_full_unstemmed	Leveraging the Treg-intrinsic CTLA4–PKCη signaling pathway for cancer immunotherapy
title_sort	leveraging the treg-intrinsic ctla4–pkcη signaling pathway for cancer immunotherapy
publisher	BMJ Publishing Group
publishDate	2021
url	https://doaj.org/article/6b0727518baf4f5588b97fc3c4c8adbd
work_keys_str_mv	AT hsinyuliu leveragingthetregintrinsicctla4pkcēsignalingpathwayforcancerimmunotherapy AT christophepedros leveragingthetregintrinsicctla4pkcēsignalingpathwayforcancerimmunotherapy AT kokfaikong leveragingthetregintrinsicctla4pkcēsignalingpathwayforcancerimmunotherapy AT annjcanonigobalancio leveragingthetregintrinsicctla4pkcēsignalingpathwayforcancerimmunotherapy AT wenxue leveragingthetregintrinsicctla4pkcēsignalingpathwayforcancerimmunotherapy AT amnonaltman leveragingthetregintrinsicctla4pkcēsignalingpathwayforcancerimmunotherapy
_version_	1718419429901991936

Leveraging the Treg-intrinsic CTLA4–PKCη signaling pathway for cancer immunotherapy

Ejemplares similares